4.7 Article

IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome

Journal

JOURNAL OF CELL BIOLOGY
Volume 187, Issue 7, Pages 1083-1099

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200909067

Keywords

-

Categories

Funding

  1. Hereditary Disease Foundation
  2. Fox Family Foundation
  3. High Q Foundation
  4. Huntington's Disease Society of America Coalition for the Cure
  5. Taube-Koret Center for Huntington's Disease Research
  6. National Institutes of Health [NS52789, HD36081, NS045283, NS043466, GM74830, 2R01NS039074, 2R01NS045191, 2P01AG022074, P01AG031782, NS055298, T32GM0731130]

Ask authors/readers for more resources

Expansion of the polyglutamine repeat within the protein Huntingtin (Htt) causes Huntington's disease, a neurodegenerative disease associated with aging and the accumulation of mutant Htt in diseased neurons. Understanding the mechanisms that influence Htt cellular degradation may target treatments designed to activate mutant Htt clearance pathways. We find that Htt is phosphorylated by the inflammatory kinase IKK, enhancing its normal clearance by the proteasome and lysosome. Phosphorylation of Htt regulates additional post-translational modifications, including Htt ubiquitination, SUMOylation, and acetylation, and increases Htt nuclear localization, cleavage, and clearance mediated by lysosomal-associated membrane protein 2A and Hsc70. We propose that IKK activates mutant Htt clearance until an age-related loss of proteasome/lysosome function promotes accumulation of toxic post-translationally modified mutant Htt. Thus, IKK activation may modulate mutant Htt neurotoxicity depending on the cell's ability to degrade the modified species.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available